Tradestie Institutional Equity Comparison Engine

RKTO vs ENVB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENVB Overall Edge

ENVB Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enveric Biosciences, Inc. Common Stock (ENVB) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RKTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ENVB at 23.1x Forward P/E and 0.0% operating margin (-7.3% YoY). In options structure, RKTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENVB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENVB
RKTO N/M vs ENVB 23.1x Fwd P/E
Growth & Margin Winner ENVB
Op Margin N/A vs 0.0% ยท YoY N/A vs -7.3%
Momentum & Technical Winner ENVB
1Y -82.5% vs -76.9% ยท 52W Pos 2% vs 2%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RKTO US Equity
RKTO
Institutional Equity
$0.30
+6.11% 1D
Market Cap N/A
1M Return -44.23%
1Y Return -82.53%
Forward P/E N/M
Unified AI Score
44.2 / 100 HOLD
Tech 45.0 Fund 42.0 Flow 50.0 Mom 55.0
ENVB NASDAQ
Enveric Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$1.35
-4.26% 1D
Market Cap $6.3M
1M Return -7.53%
1Y Return -76.88%
Forward P/E 23.1x
Unified AI Score
40.6 / 100 SELL
Tech 33.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RKTO -82.53% ENVB -76.88% Spread: +40.72 pp (ENVB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RKTO TTM Op. Margin: N/A ENVB TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RKTO vs ENVB. Trailing 12-month operating profitability (RKTO N/A vs ENVB 0.0%) and valuation multiples (RKTO N/M vs ENVB 23.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RKTO (1) vs ENVB (8)
Institutional Metric RKTO ENVB Criterion Row Winner
Market Capitalization Scale N/A $6.3M Larger Scale ENVB
Trailing P/E Ratio Valuation N/M 23.1x Lower Multiple ENVB
Forward P/E Ratio Valuation N/M 23.1x Lower Multiple ENVB
Revenue Growth (YoY) Growth N/A -7.3% Higher Growth ENVB
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin ENVB
Net Profit Margin Profitability N/A 0.0% Higher Margin ENVB
Return on Equity (ROE) Capital Efficiency N/A -170.0% Higher ROE ENVB
52-Week Range Position Momentum 2% ($0โ€“$2) 2% ($1โ€“$13) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.16ฮฒ ยท 63% Vol 0.65ฮฒ ยท 44% Vol Lower Realized Risk ENVB
Unified Institutional Score Composite Signal 44.2 / 100 (HOLD) 40.6 / 100 (SELL) Higher Composite RKTO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RKTO vs ENVB Buy Guide
RKTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RKTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENVB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RKTO nor ENVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.